BioSpace News Archive

The significant rise in surgical procedures for organ transplants may bring multiple growth opportunities for the biological implants market during the forecast period of 2021-2031.

Albany NY, United States: Due to the rising prevalence of various disorders such as multiple sclerosis, inflammatory bowel disease, autoimmune diseases, and psoriasis, the global anti-inflammatory peptides market is predicted to observe growth during the forecast period.

Albany NY, United States: The products and solutions offered by the players and participants in the global stereotactic surgery devices market enable a surgical procedure used for performing actions such as biopsy, injection, implantation, radiosurgery, ablation, lesion, and stimulation.

An irradiation apparatus is an electric device designed for creating ionized radiation or emitting ionized ration as an end-product having stated limitations.

The global rehabilitation equipment market is expected to expand at a CAGR of 5.2% during the forecast period of 2020 to 2025.

Nicox SA announced that its Board of Directors appointed Andreas Segerros as Chief Executive Officer of Nicox S.A on May 13th, 2022, effective from June 1st, 2022, following the Board’s decision to end the mandate of Michele Garufi, who has been Chairman, Chief Executive Officer and Co-Founder of the Company since its creation in 1996.

Atamyo Therapeutics announced multiple major milestones for ATA-100 and ATA-200, its one-time gene-replacement therapies for the treatment of limb-girdle muscular dystrophy types 2I/R9 and 2C/R5, as well as the reinforcement of its management team.

Royal Philips, a global leader in health technology, announced at EuroPCR the international launch of EchoNavigator 4.0 [1], the new release of its advanced image-guided therapy solution for the treatment of structural heart disease.

Royal Philips, a global leader in health technology, is showcasing innovations at EuroPCR that can enable interventionists to perform ultra-low contrast percutaneous coronary intervention procedures with greater confidence and clarity.

Proteros biostructures GmbH, an expert in integrated structure-based drug discovery, announces an expansion of its collaboration with AstraZeneca focused on the discovery and development of novel epigenetic drugs.